Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Flood

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
The Lancet. Global Health|September 25, 2021
Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation modelSanjay Basu, David Flood, Pascal Geldsetzer, et al.
Nature Human Behaviour|March 14, 2024
The prevalence of cardiovascular disease risk factors among adults living in extreme povertyPascal Geldsetzer, Rebecca L Tisdale, Lisa Stehr, et al.
The Lancet. Global Health|February 18, 2022
Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level dataMaja E Marcus, Jennifer Manne-Goehler, Michaela Theilmann, et al.
BMJ Global Health|June 7, 2020
Prioritising the role of community health workers in the COVID-19 responseMadeleine Ballard, Emily Bancroft, Josh Nesbit, et al.
Nature Communications|August 4, 2025
National evidence on glucose-lowering medication use for diabetes from 62 low- and middle-income countriesFelix Teufel, Pia Roddewig, Maja E Marcus, et al.
Nature Medicine|January 26, 2024
Hypertension care cascades and reducing inequities in cardiovascular disease in low- and middle-income countriesDorit Talia Stein, Marissa B Reitsma, Pascal Geldsetzer, et al.
Bulletin of the World Health Organization|November 3, 2025
Use of traditional medicine for hypertension, diabetes and hypercholesterolaemia measured in 71 surveysMubarak Ayodeji Sulola, Abla M Sibai, Albertino Damasceno, et al.
The Lancet. Healthy Longevity|February 25, 2022
The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adultsDavid Flood, Jacqueline A Seiglie, Matthew Dunn, et al.
The Lancet. Global Health|September 21, 2023
Diabetes risk and provision of diabetes prevention activities in 44 low-income and middle-income countries: a cross-sectional analysis of nationally representative, individual-level survey dataNicholas Errol Rahim, David Flood, Maja E Marcus, et al.
JAMA|August 22, 2023
Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income CountriesSang Gune K Yoo, Grace S Chung, Silver K Bahendeka, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
The Lancet. Global Health|September 25, 2021
Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation modelSanjay Basu, David Flood, Pascal Geldsetzer, et al.
Nature Human Behaviour|March 14, 2024
The prevalence of cardiovascular disease risk factors among adults living in extreme povertyPascal Geldsetzer, Rebecca L Tisdale, Lisa Stehr, et al.
The Lancet. Global Health|February 18, 2022
Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level dataMaja E Marcus, Jennifer Manne-Goehler, Michaela Theilmann, et al.
BMJ Global Health|June 7, 2020
Prioritising the role of community health workers in the COVID-19 responseMadeleine Ballard, Emily Bancroft, Josh Nesbit, et al.
Nature Communications|August 4, 2025
National evidence on glucose-lowering medication use for diabetes from 62 low- and middle-income countriesFelix Teufel, Pia Roddewig, Maja E Marcus, et al.
Nature Medicine|January 26, 2024
Hypertension care cascades and reducing inequities in cardiovascular disease in low- and middle-income countriesDorit Talia Stein, Marissa B Reitsma, Pascal Geldsetzer, et al.
Bulletin of the World Health Organization|November 3, 2025
Use of traditional medicine for hypertension, diabetes and hypercholesterolaemia measured in 71 surveysMubarak Ayodeji Sulola, Abla M Sibai, Albertino Damasceno, et al.
The Lancet. Healthy Longevity|February 25, 2022
The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adultsDavid Flood, Jacqueline A Seiglie, Matthew Dunn, et al.
The Lancet. Global Health|September 21, 2023
Diabetes risk and provision of diabetes prevention activities in 44 low-income and middle-income countries: a cross-sectional analysis of nationally representative, individual-level survey dataNicholas Errol Rahim, David Flood, Maja E Marcus, et al.
JAMA|August 22, 2023
Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income CountriesSang Gune K Yoo, Grace S Chung, Silver K Bahendeka, et al.
Pageof 8